StemCells (STEM) Submits Protocol to U.S. FDA for HuCNS-SC Second Clinical Initiation
Tweet Send to a Friend
StemCells, Inc. (Nasdaq: STEM) announced today that it has submitted a protocol to the FDA for initiation of a second ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
